Prostate cancer is the most commonly diagnosed cancer in American men — and the second leading cause of cancer-related deaths. One in eight men will be diagnosed in their lifetime. And Black men are ...
Johns Hopkins researchers have identified a WIF1-expressing basal epithelial cell type concentrated in the prostate's ...
Researchers at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center have identified a distinct type of prostate cell ...
The double vision can be a symptom of tumors affecting the eye muscles or nerves; the changes in eye appearance, ie, a sunken or bulging eye might be a sign of a tumor in the orbit.Horner's syndrome ...
Fagundes, MD, discussed when proton therapy is most justified over photon approaches in prostate cancer. In an interview with ...
Prostate cancer has a well-earned reputation for being one of the more trackable malignancies in medicine. Since the mid-1980s, a single blood test measuring prostate-specific antigen, or PSA, has ...
Intensity-modulated proton therapy (IMPT) allows radiation oncologists to limit the dose to organs surrounding the prostate. That property may be particularly relevant for patients with prostate ...
While ADT can reduce the risk of recurrence and distant spread, it can also have metabolic and quality-of-life effects. Because intermediate-risk disease is biologically diverse, clinical variables ...
A case report led by UCLA Health researchers highlights the importance of a multidisciplinary, evidence-based approach to ...
Opinion: One in 44 men will die of prostate cancer. This is unfortunate because it is among the most treatable cancers when ...
Stereotactic body radiation therapy significantly improved quality of life outcomes, including urinary incontinence and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results